RSS
chronic lung disease
On the fast track: Shire receives fast track designation for SHP607
Biotech company, Shire, has been granted fast track designation by the US Food and Drug Administration (FDA) for SHP607, which is indicated for the prevention of chronic lung disease in extremely premature infants. more
